Damora Therapeutics (DMRA) Enterprise Value Growth (1y) (2020 - 2026)
Damora Therapeutics (DMRA) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,280.03% |
| Dec 31, 2025 | -1,717.45% |
| Sep 30, 2025 | 61.39% |
| Jun 30, 2025 | 19.81% |
| Mar 31, 2025 | 77.96% |
| Dec 31, 2024 | 61.67% |
| Sep 30, 2024 | 67.73% |
| Jun 30, 2024 | 75.57% |
| Mar 31, 2024 | 48.97% |
| Dec 31, 2023 | 38.59% |
| Sep 30, 2023 | 39.84% |
| Jun 30, 2023 | 58.92% |
| Mar 31, 2023 | 43.11% |
| Dec 31, 2022 | 39.89% |
| Sep 30, 2022 | 0.65% |
| Jun 30, 2022 | -24.63% |
| Mar 31, 2022 | 15.17% |
| Dec 31, 2021 | 38.75% |
| Sep 30, 2021 | -19.70% |
| Jun 30, 2021 | -184.06% |